Laryngeal Neoplasms [clinicaltrials_resource:02d0905b9c9aa0d04177443abf532e07]
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants [clinicaltrials:NCT00127465]Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy [clinicaltrials:NCT00396617]Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA [clinicaltrials:NCT00534729]The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement [clinicaltrials:NCT00576134]Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract [clinicaltrials:NCT00721539]clinicaltrials:NCT00721799Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab [clinicaltrials:NCT00941135]MRI Imaging of the Human Larynx [clinicaltrials:NCT00965003]Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers [clinicaltrials:NCT01104714]Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma [clinicaltrials:NCT01171235]clinicaltrials:NCT01216020Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance [clinicaltrials:NCT01257633]Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms [clinicaltrials:NCT02430675]
condition [clinicaltrials_vocabulary:condition]
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) [clinicaltrials:NCT00001126]The Effects of Upper Airway and Digestive Tract Tumors on the Immune System [clinicaltrials:NCT00001603]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer [clinicaltrials:NCT00004256]Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00023959]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) [clinicaltrials:NCT00031681]Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [clinicaltrials:NCT00033449]Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck [clinicaltrials:NCT00033618]Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [clinicaltrials:NCT00049283]Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [clinicaltrials:NCT00055770]Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00055913]Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [clinicaltrials:NCT00063895]Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer [clinicaltrials:NCT00068497]Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck [clinicaltrials:NCT00081211]clinicaltrials:NCT00084682Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00089362]SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00095628]S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer [clinicaltrials:NCT00095641]S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00096512]Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [clinicaltrials:NCT00098631]Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [clinicaltrials:NCT00101348]clinicaltrials:NCT00103259Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [clinicaltrials:NCT00114283]Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants [clinicaltrials:NCT00127465]clinicaltrials:NCT00128817clinicaltrials:NCT00387335Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy [clinicaltrials:NCT00396617]Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [clinicaltrials:NCT00397384]Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00407810]clinicaltrials:NCT00410826Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer [clinicaltrials:NCT00470496]clinicaltrials:NCT00492089clinicaltrials:NCT00507767Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) [clinicaltrials:NCT00508664]clinicaltrials:NCT00513435Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA [clinicaltrials:NCT00534729]The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement [clinicaltrials:NCT00576134]Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract [clinicaltrials:NCT00721539]clinicaltrials:NCT00721799
condition browse [clinicaltrials_vocabulary:condition-browse]
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) [clinicaltrials:NCT00001126]The Effects of Upper Airway and Digestive Tract Tumors on the Immune System [clinicaltrials:NCT00001603]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer [clinicaltrials:NCT00004256]Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00023959]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) [clinicaltrials:NCT00031681]Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [clinicaltrials:NCT00033449]Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck [clinicaltrials:NCT00033618]Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [clinicaltrials:NCT00049283]Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [clinicaltrials:NCT00055770]Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00055913]Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [clinicaltrials:NCT00063895]Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer [clinicaltrials:NCT00068497]Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck [clinicaltrials:NCT00081211]clinicaltrials:NCT00084682Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00089362]SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00095628]S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer [clinicaltrials:NCT00095641]S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00096512]Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [clinicaltrials:NCT00098631]Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [clinicaltrials:NCT00101348]clinicaltrials:NCT00103259Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [clinicaltrials:NCT00114283]Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants [clinicaltrials:NCT00127465]clinicaltrials:NCT00128817clinicaltrials:NCT00387335Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy [clinicaltrials:NCT00396617]Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [clinicaltrials:NCT00397384]Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [clinicaltrials:NCT00407810]clinicaltrials:NCT00410826Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer [clinicaltrials:NCT00470496]clinicaltrials:NCT00492089clinicaltrials:NCT00507767Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) [clinicaltrials:NCT00508664]clinicaltrials:NCT00513435Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA [clinicaltrials:NCT00534729]The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement [clinicaltrials:NCT00576134]Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract [clinicaltrials:NCT00721539]clinicaltrials:NCT00721799
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Laryngeal Neoplasms [clinicaltrials_resource:02d0905b9c9aa0d04177443abf532e07]
Bio2RDF identifier
02d0905b9c9aa0d04177443abf532e07
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:02d0905b9c9aa0d04177443abf532e07
identifier
clinicaltrials_resource:02d0905b9c9aa0d04177443abf532e07
title
Laryngeal Neoplasms
@en
type
label
Laryngeal Neoplasms [clinicaltrials_resource:02d0905b9c9aa0d04177443abf532e07]
@en
Laryngeal Neoplasms